Clinical Trial Update: Ketamine Efficacy for Acute Severe Bronchospasm in ICU: MACANUDO Trial [Phase 2, Phase 3]

View source ↗

Summary

The MACANUDO trial evaluated ketamine for acute severe bronchospasm in ICU patients with asthma/critical illness, and has completed Phase 2 and Phase 3 cohorts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Bronchospasm

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Hospital Nossa Senhora da Conceicao | Conditions: Critical Illness, Asthma | Phase 2, Phase 3 | Status: COMPLETED